Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged ... ( ORANGE COUNTY Calif. Aug. 22 /- B...)

Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference

Date:8/22/2008

ORANGE COUNTY, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Paul Glyer, Beckman Coulter's senior vice president of Corporate Strategy and Business Development, will present at the Morgan Stanley Healthcare Unplugged Conference on Tuesday, September 9, 2008 at 3:55 p.m. (ET).

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The live webcast of Beckman Coulter's presentation can be accessed by visiting their website at http://www.beckmancoulter.com. To access the webcast select "go to IR" under Investor Relations and find the event listed under "What's Ahead." The webcast will be archived on the company's website for future on-demand replay through Tuesday, October 28, 2008.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78 percent of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Contact: Cynthia Skoglund (714) 773-8213

Manager, In
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
2. Beckman Coulter Announces Second Quarter 2008 Results
3. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
4. Upcoming Beckman Coulter Investor Events Second Half of 2008
5. Beckman Coulter to Present at Upcoming Healthcare Conferences
6. Beckman Coulter Announces First Quarter 2008 Results
7. Beckman Coulter Acquires Rights to Hepatitis C Virus
8. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
9. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
10. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
11. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell

Post Your Comments:

(Date:12/1/2009)... , SARASOTA, Fla., Dec. 1 ...s, Osprey Biotechnics Inc. of Sarasota has appoint...tributor. ,, Lake is located near Birmingham, ...ial bacteria which serve the agricultural, waste w...bred to be hungry and to open drain fields, and cl...

(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 The... almost half the value it lost in October. The Sel...n excellent month for the general markets with the...in value. The gains held firm in the final two tra...out sluggish Thanksgiving holiday shopping and Dub...

(Date:12/1/2009)... EpiVax, Inc. today announce...IX: RO, ROG; OTCQX: RHHBY) aimed at evaluating Epi...h could potentially reduce detrimental immune resp...-EpiVax collaboration, the EpiVax Tregitope techno...nogenicity of protein therapeutics. , ...

(Date:12/1/2009)... , CRANBURY, N.J., Dec. 1 /PRNewswire-FirstC...N ) today announced that the U.S. Patent and Trade...titled "Cyclic Natriuretic Peptide Constructs." T...yclic compounds that bind to natriuretic peptide r...d heart failure drug candidate. ,, "Our natriur...

Breaking Biology Technology:Biotech Gets Back on Track in November 2 Biotech Gets Back on Track in November 3 Biotech Gets Back on Track in November 4 EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2 EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3 Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2 Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3

[0] Osprey Expands In Europe [0] Biotech Gets Back on Track in November [0] EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology [0] Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate

...swire-FirstCall/ -- Pharmaxis,(ASX: PXS, Nasdaq: P...mannitol) has been included as an approved test by... Medical Commission., The approval was contained ...Asthma in Elite Athletes, for athletes competing i...n elite athletes has grown,exponentially in recent...

...tfolio of Cardiovascular Solutions, CHICAGO, Marc...com/healthcare ) will demonstrate how its laborato... (IT) solutions are helping,to "Bring a New Rhythm...tific Session of the American College of Cardiolog...06., (Logo: http://www.newscom.com/cgi-bin/prnh/...

...oftware Inc., a leading,provider of web-based empl...s sponsored an IDC case study which profiles Flori...d for this study based on its best-practice,driven...ement, which,includes the use of Halogen,s product...erformance Management: A Case,Study on O,Sullivan ...

Other Biology Technology:Aridol(TM) Endorsed by International Olympic Committee 2 Aridol(TM) Endorsed by International Olympic Committee 3 Aridol(TM) Endorsed by International Olympic Committee 4 Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 2 Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 3 Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 4 Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 5 New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management 2

Aridol(TM) Endorsed by International Olympic Committee Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management

(Date:12/2/2009)...only prescribed beta 2 adrenergic agonist drugs fo...l as pre-term labor may increase the incidence of ...cognitive problems and poor school performance in ... in the December 2009 issue of the American Journ...gic agonist drugs as a class are widely used in ob...

(Date:12/2/2009)...ding to the National Institute of Health, 40 perce...tes already have some stage of diabetic retinopath...sed by leaky blood vessels, is a major cause of bl...most feared diabetic complications. In fact, up t...or 10 years or more will experience some form of d...

(Date:12/1/2009)...d to announce the publication of results from its ... and tolerability of its novel, intranasal drug/de...rhinosinusitis with nasal polyps in Rhinology , t...ean Rhinologic Societies. , Chronic rhinosinusi...n significantly reduce a patient,s quality of life...

[0] Treatments for asthma and pre-term labor may increase risk of autism in developing fetus [3] Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy [0] New data on highly effective treatment for chronic rhinosinusitis with nasal polyps

...pothesis that combination antiretroviral drug ther...nsmission through breastfeeding, findings that cou... world. , Researchers in the first study found mot...reastfeeding infants in concentrations high enough...els of HIV RNA in breast milk are lower in mothers...

...essor of physics at Virginia Tech, has been awarde... from Oak Ridge Associated Universities to continu...s modeling the sequence of events that initiate ac...ce it has reached a critical size. , The Powe awar... who are in the first two years of their tenure tr...

...rely on their healthcare providers to learn about ...ir doctor has talked to them about cervical cancer...according to a new survey released by the Associat...PV is extremely common, affecting an estimated 80 ...e, in some cases staying dormant until years after...

Other Biology News:Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants 2 Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants 3 Understanding how bacteria communicate may help scientists prevent disease 2 Understanding how bacteria communicate may help scientists prevent disease 3 Survey reveals women and doctors aren't talking about HPV 2 Survey reveals women and doctors aren't talking about HPV 3

Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants Understanding how bacteria communicate may help scientists prevent disease Survey reveals women and doctors aren't talking about HPV

Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories

GIBCO Donor Calf Serum from Invitrogen

...agicMark XP Western Protein Standards are specific...cular weight estimation directly on western blots....e, allowing direct visualization with the same ant...t protein on the blots. Colorimetric, chemilumines...

Genetic Mapping of Disease Genes from Promega

Biology Products:

Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories GIBCO Donor Calf Serum from Invitrogen MagicMark XP Western Protein Standard from Invitrogen Genetic Mapping of Disease Genes from Promega

Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged ...( ORANGE COUNTY Calif. Aug. 22 /- B...)